Target intelligence / Profile preview

Centrosomal protein 57 (CEP57)

Target
CEP57
Molecular classification
Other (coiled-coil scaffold protein, centrosomal/pericentriolar matrix protein)
01

Overview

Centrosomal protein 57 (CEP57) is a highly conserved coiled-coil scaffold protein localized at the pericentriolar matrix of the centrosome, essential for organizing the structure and function of centrosomes in vertebrate cells. It plays a central role in controlling centriole duplication, centrosome maturation, and microtubule nucleation. CEP57 is responsible for the engagement of centrioles during interphase and mitosis, acting as a structural hub for recruiting other critical PCM proteins such as Cep63 and Cep152, which are necessary for centrosome maturation and subsequent cell division fidelity[1][2][3][4][5]. CEP57 dynamically assembles via multivalent interactions and undergoes liquid–liquid phase separation, a process that is crucial for PCM expansion and the formation of microtubule asters. Truncating mutations in CEP57 cause mosaic-variegated aneuploidy syndrome, characterized by abnormal chromosome numbers and spindle defects[1][2]. Aberrant expression or depletion of CEP57 leads to centrosome amplification, PCM disorganization, and defects in mitotic spindle formation. Its function has implications for cancer biology due to its role in maintaining genomic integrity during cell division[3]. As of now, no drugs are known to specifically target CEP57, nor is it used as a clinical biomarker, but its role in cell division control makes it a relevant investigational target for mitosis-related disorders.

Other names
Centromatrix protein of 57 kDaKIAA0092TSP57TranslokinFGF2-interacting proteinTestis-specific protein 57MVA2PIG8proliferation-inducing protein 8
02

Biological functions

Centrosome maturationCentriole duplicationMicrotubule nucleation and bundlingMaintains centriole engagementCell cycle regulation
03

Disease associations

Cancer (impacts microtubule network integrity; relevant to spindle assembly in mitosis; implicated in centrosome amplification)Mosaic-variegated aneuploidy (MVA) syndrome

Beyond the preview

Go deeper on Centrosomal protein 57 (CEP57).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centrosomal protein 57 (CEP57).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call